Related Experiment Video
Updated: Apr 12, 2026

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
Published on: July 12, 2024
Drivers of reduction in PM2.5 concentrations and related health risks in China from 2013 to 2023
Fenfen Zhang1, Rui Liu2, Mei Wan2
1Department of Environment, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, Jiaxing, 314006, China; State Key Laboratory of Regional Environment and Sustainability, School of Environment, Tsinghua University, Beijing, 100084, China; State Environmental Protection Key Laboratory of Sources and Control of Air Pollution Complex, Beijing, 100084, China.
Abstract:
From 2013 to 2023, China implemented three phases clean air actions, resulted in significantly reduction in ambient fine particles matter (PM2.5) concentration. However, the phase-specific driving factors behind PM2.5 changes and associated health benefits over this period have not been comprehensively investigated. Here, we quantify the public health burden attributable to changes in PM2.5 concentration, using an integrated framework that combines an emission inventory model, a chemical transport model, and a health risk assessment model. We found that the national PM2.5 concentration decreased substantially by 20.7 μg m-3 (36.8%) during Phase Ⅰ (2013-2017), 4.3 μg m-3 (7.6%) during Phase Ⅱ (2017-2020), and 0.7 μg m-3 (12.1%) during Phase Ⅲ (2020-2023). These reductions led to approximately 0.46 (95% Confidence Interval: 0.40-0.51) million, 0.18 (95%CI: 0.16-0.21) million, and 0.27 (95%CI: 0.23-0.31) million avoided premature deaths, respectively. Considering the influence of driving factors for air pollution control, the contribution of anthropogenic emissions declined markedly from 18.2 μg m-3 in Phase Ⅰ to 3.5 μg m-3 in Phase Ⅱ and 2.0 μg m-3 in Phase Ⅲ, respectively. In contrast, meteorological conditions shifted from reducing PM2.5 concentration in Phases I and II (-2.5 and -0.8 μg m-3) to increasing it in Phase III (+1.3 μg m-3). The diminishing marginal effectiveness of air quality improvement during Phase Ⅱ and Phase Ⅲ was attributed to both the saturation of end-of-pipe control technologies and increasingly unfavorable meteorological conditions. Although PM2.5 reduction potentials substantially diminished after 2020, the PM2.5-related avoided deaths in Phase Ⅲ accounted for 29.8% of total cases, exceeding that of Phase Ⅱ (20.0%) and revealing a nonlinear health response. Our results underscore that health-oriented collaborative strategies for air pollution and climate mitigation are critical for achieving substantial air quality improvements in the future.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
08:59Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System
Published on: May 22, 2020
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Stress Prevention and Stress Management Techniques IV